A technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: ReutersA technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: Reuters
A technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: Reuters

CanSino gets Russia’s approval to start Covid-19 vaccine trials on humans after snubbing Canada

  • Approval from Moscow comes after CanSino ended a cooperation with Canada’s National Research Council for unexplained reasons
  • Company plans to build a facility capable of producing 200 million doses of vaccine annually, co-founder Yu Xuefeng says

Topic |   Coronavirus pandemic
A technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: ReutersA technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: Reuters
A technician works at a CanSino Biologics manufacturing facility in Tianjin, China. The firm has gained approval to conduct human trials in Russia. Photo: Reuters
READ FULL ARTICLE